Metformin for Weight Loss: How It Works, How Much to Expect, and Who It’s For

Metformin can cause modest weight loss — about 2% to 3% of body weight over the first year in major prevention studies. It works best in people with insulin resistance, prediabetes, type 2 diabetes, or PCOS. It is not FDA-approved for weight loss, and results are usually smaller than with GLP-1 medications like semaglutide or tirzepatide.[1][2][3]

What is metformin, and what is it approved for?

Metformin is the generic name for a biguanide drug. Brand names include Glucophage, Glucophage XR, Fortamet, Glumetza, and Riomet. The FDA-approved use is to improve blood sugar control in adults and children with type 2 diabetes, along with diet and exercise.[3]

Metformin is not FDA-approved as a weight-loss medication. Still, clinicians sometimes consider it off-label for people who may benefit metabolically, such as those with prediabetes, insulin resistance, or polycystic ovary syndrome, also called PCOS.[1][4] Possible benefits must be weighed against stomach side effects, vitamin B12 deficiency, kidney-related limits, and rare lactic acidosis risk.[3][5]

Brand names: Glucophage, Fortamet, Glumetza, and Riomet

Metformin comes in immediate-release tablets, extended-release tablets, and oral solutions. Glucophage and Riomet are examples of immediate-release or liquid forms, while Glucophage XR, Fortamet, and Glumetza are extended-release brands.[3] Extended-release forms may be easier on the stomach for some people, but a clinician still needs to decide what is appropriate.

FDA-approved use vs. off-label use for weight

FDA approval means a medication has been reviewed for a specific use, dose range, population, and label. Metformin’s label is for type 2 diabetes, not chronic weight management.[3] Off-label prescribing can be medically appropriate in some cases, but it should include a clear reason, a safety review, and follow-up.

How does metformin cause weight loss?

Metformin may affect weight through several pathways, not one single switch. It lowers liver glucose production and improves insulin sensitivity, which may reduce high insulin signaling in people with insulin resistance.[3] These effects may support modest weight loss, but stomach upset, appetite changes, kidney function, and contraindications still matter.[3]

Effect on liver glucose production and insulin sensitivity

Metformin mainly reduces how much glucose the liver releases and helps the body use insulin more effectively.[3] For people with insulin resistance or prediabetes, this can improve blood sugar patterns and may make weight management easier. It does not directly burn fat, and it does not replace nutrition, activity, sleep, or medical care.

The lac-phe pathway: appetite signaling from the gut

A newer research area involves lac-phe, short for N-lactoyl-phenylalanine. A 2024 study found that metformin can raise lac-phe levels, a molecule linked with appetite regulation after exercise, which may help explain part of metformin-related weight change.[10] This is still an active research area, and it does not remove the need to monitor side effects or safety.

Effects on appetite, cravings, and gut bacteria

Some studies suggest metformin can change gut bacteria and appetite-related signaling.[11] These changes may be helpful for some patients, but responses vary. Gastrointestinal side effects like nausea, diarrhea, and gas are also common, especially early in treatment.[3]

How much weight can you lose on metformin?

In the Diabetes Prevention Program, metformin was linked with about 2% to 3% average body-weight loss in the first year, while intensive lifestyle change led to more weight loss on average.[1] That means results are usually modest. Side effects, kidney function, and B12 levels still need attention during use.[3][5]

Average results: 2% to 3% of body weight in year one

In the Diabetes Prevention Program, participants were assigned to lifestyle change, placebo, or metformin; the metformin group received 850 mg twice daily as part of the study protocol.[1] After about 2.8 years, the metformin group lost about 2.1 kg on average compared with about 0.1 kg in the placebo group.[1] Individual results vary, and this trial was not a cosmetic weight-loss study.

Long-term maintenance over 10 to 15 years

Follow-up data from the Diabetes Prevention Program Outcomes Study found that some participants maintained weight loss over many years while continuing metformin in the study setting.[2] Long-term use also raises long-term safety needs, including watching for vitamin B12 deficiency and avoiding use when kidney function is too low.[3][5]

How it compares to GLP-1s like semaglutide and tirzepatide

Average weight loss with GLP-1-based medications is usually larger than with metformin. In the STEP 1 trial, participants receiving semaglutide 2.4 mg once weekly plus lifestyle intervention had about 14.9% mean body-weight loss at 68 weeks.[6] In the SURMOUNT-1 trial, participants receiving tirzepatide 5 mg, 10 mg, or 15 mg once weekly plus lifestyle intervention had about 15.0% to 20.9% mean body-weight loss at 72 weeks.[7] Individual results vary, and these medications can cause nausea, vomiting, diarrhea, constipation, gallbladder problems, pancreatitis warnings, kidney concerns, and thyroid C-cell tumor contraindications or warnings.[8][9]

How fast does metformin work for weight loss?

Some people notice appetite or stomach changes within the first 4 weeks, but measurable weight change often takes several months. In studies, the clearest weight patterns were measured over 6 to 12 months or longer.[1][2] Early side effects can happen before any weight change appears.[3]

What to expect in the first month

The first month is often more about tolerance than weight loss. Nausea, diarrhea, gas, or a metallic taste can occur, especially when therapy begins or changes.[3] If weight changes happen early, they are usually small and may be related to lower appetite or less food intake.

Factors that influence your results

• Baseline insulin resistance, prediabetes, type 2 diabetes, or PCOS status may affect response.[1][4]
• Nutrition, activity, sleep, alcohol use, and other medications can change weight outcomes.
• Stomach side effects may limit use or lead to stopping therapy.[3]
• Kidney function and other health conditions affect whether metformin is appropriate.[3]
• Individual results vary; metformin does not guarantee weight loss.

Can a non-diabetic person take metformin for weight loss?

A non-diabetic person may be prescribed metformin off-label in selected cases, such as prediabetes, insulin resistance, or PCOS. This is not the same as FDA approval for weight loss.[3][4] Benefits are usually modest, and safety checks are still needed.

Evidence in adults with obesity and no diabetes

The Diabetes Prevention Program studied adults with elevated diabetes risk, not people seeking cosmetic weight loss. Metformin reduced diabetes progression and caused modest average weight loss compared with placebo.[1] Because the study population had high diabetes risk, the results may not apply to every non-diabetic person.

Who benefits most

People most likely to be considered for metformin often have signs of insulin resistance, prediabetes, type 2 diabetes, or PCOS.[1][4] In PCOS, metformin has been studied for metabolic and reproductive features, but it is not FDA-approved as a PCOS weight-loss drug.[4] Side effects and kidney-related limits still apply.[3]

Who is unlikely to benefit

A person without insulin resistance, prediabetes, type 2 diabetes, or PCOS may be less likely to see meaningful weight change. Metformin is also not appropriate for some people with significant kidney impairment, certain acute illnesses, or conditions that raise lactic acidosis risk.[3]

What’s the typical metformin dosage for weight loss?

There is no FDA-approved metformin dosage for weight loss because weight loss is an off-label use.[3] For approved diabetes treatment, FDA labels describe starting amounts and gradual titration based on response and tolerability, but the right plan depends on a clinician’s evaluation. Higher amounts can mean more side effects, not better weight loss.

Starting dose and titration

For FDA-approved type 2 diabetes treatment, the Glucophage label describes an initial adult dose of 500 mg twice daily or 850 mg once daily with meals, with gradual increases as needed and tolerated.[3] This is label information, not a dosing instruction for weight loss. A licensed clinician must decide whether metformin is appropriate and how it should be used.

Immediate-release vs. extended-release

For FDA-approved type 2 diabetes treatment, the Glucophage XR label describes an initial adult dose of 500 mg once daily with the evening meal, with changes based on glycemic control and tolerability.[3] Immediate-release and extended-release products are not interchangeable without clinician guidance. Extended-release forms may reduce stomach symptoms for some people, but they are not risk-free.

Why higher doses don’t always mean more weight loss

Metformin’s weight effect tends to be modest, and more medication does not always mean more weight loss. Higher exposure may increase diarrhea, nausea, and other gastrointestinal side effects.[3] A clinician may also need to consider kidney function and B12 monitoring.[3][5]

What are the side effects and risks of metformin?

Metformin is widely used, but it still has risks. Common side effects include diarrhea, nausea, vomiting, gas, indigestion, and stomach discomfort.[3] Long-term use is linked with vitamin B12 deficiency, and rare lactic acidosis can be serious, especially in higher-risk patients.[3][5]

Common GI side effects

• Diarrhea, nausea, vomiting, and stomach pain are among the most common side effects.[3]
• Gas, indigestion, weakness, headache, and a metallic taste can also occur.[3]
• Symptoms may be worse when treatment starts or changes.
• Severe or lasting symptoms should be reviewed by a clinician.

Vitamin B12 deficiency with long-term use

Long-term metformin use can lower vitamin B12 levels. In the Diabetes Prevention Program Outcomes Study, low or borderline-low B12 was more common in the metformin group than placebo at certain follow-up points.[5] Symptoms can include fatigue, numbness, tingling, or anemia, and testing may be needed.

Lactic acidosis and kidney considerations

Metformin carries a boxed warning for lactic acidosis, a rare but serious buildup of acid in the blood.[3] Risk is higher in certain settings, including significant kidney impairment, dehydration, severe infection, low oxygen states, liver disease, heavy alcohol use, or some imaging procedures with iodinated contrast.[3]

Signs of misuse and disordered eating

Using metformin without a prescription, using someone else’s medication, or using it to suppress appetite despite medical risk can be unsafe. If weight-loss efforts feel driven by fear, guilt, purging, or loss of control, it is important to seek support from a qualified clinician or mental health professional.

Metformin vs. Ozempic, Wegovy, and compounded GLP-1s: how do they compare?

Metformin and GLP-1 medications are different tools. Metformin is an oral biguanide approved for type 2 diabetes, while Ozempic and Wegovy are semaglutide products in the GLP-1 receptor agonist class, and Mounjaro and Zepbound are tirzepatide products that act on GIP and GLP-1 receptors.[3][8][9][12] Their benefits, risks, FDA status, and access paths differ.

How do you get metformin or a GLP-1 through a licensed provider?

The safest path is a clinical evaluation that reviews your health history, current medications, labs, weight-related risks, pregnancy status when relevant, kidney function, and treatment goals. Eligibility for metformin or a GLP-1 is not based on weight alone. It also depends on FDA-approved indications, off-label considerations, contraindications, and monitoring needs.[3][8][9][12][13]

Compounded semaglutide and compounded tirzepatide may be discussed when clinically appropriate and legally available. These are prepared by state-licensed 503A pharmacies for individual prescriptions, but they are not FDA-approved products and are not reviewed by FDA for safety, effectiveness, or quality as finished drugs.[14]

Chia is one option among licensed telehealth providers for clinician-reviewed access to compounded GLP-1 treatment and longevity-peptide care when appropriate. A clinician can help compare metformin, FDA-approved GLP-1 medications, compounded options, and non-medication care without promising a specific result.

Frequently asked questions

Keep reading

Weight Loss Medications

Metformin Dose for Weight Loss: What the Evidence Actually Shows

Weight Loss Medications

Is 500 mg of Metformin a Low Dose for Weight Loss?

Metabolic Health

Metformin Side Effects: What to Expect and How to Manage Them